$4.23
2.67% today
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US82657M1053
Symbol
SGHT

Sight Sciences Inc Stock price

$4.23
+0.66 18.49% 1M
+1.77 71.95% 6M
+0.59 16.21% YTD
-2.09 33.07% 1Y
-3.50 45.28% 3Y
-29.27 87.37% 5Y
-29.27 87.37% 10Y
-29.27 87.37% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.11 2.67%

Key metrics

Basic
Market capitalization
$215.8m
Enterprise Value
$154.1m
Net debt
positive
Cash
$101.5m
Shares outstanding
52.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.8 | 2.9
EV/Sales
2.0 | 2.1
EV/FCF
negative
P/B
3.1
Financial Health
Equity Ratio
61.3%
Return on Equity
-58.9%
ROCE
-44.2%
ROIC
-
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$76.3m | $73.9m
EBITDA
$-48.0m | $-46.2m
EBIT
$-48.6m | $-54.8m
Net Income
$-49.0m | $-61.6m
Free Cash Flow
$-22.6m
Growth (TTM | estimate)
Revenue
-3.9% | -7.5%
EBITDA
6.3% | 7.3%
EBIT
6.4% | -8.5%
Net Income
6.3% | -19.5%
Free Cash Flow
37.7%
Margin (TTM | estimate)
Gross
85.5%
EBITDA
-62.9% | -62.5%
EBIT
-63.7%
Net
-64.2% | -83.3%
Free Cash Flow
-29.7%
More
EPS
$-1.0
FCF per Share
$-0.4
Short interest
2.9%
Employees
216
Rev per Employee
$370.0k
Show more

Is Sight Sciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Sight Sciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Sight Sciences Inc forecast:

7x Buy
54%
6x Hold
46%

Analyst Opinions

13 Analysts have issued a Sight Sciences Inc forecast:

Buy
54%
Hold
46%

Financial data from Sight Sciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
76 76
4% 4%
100%
- Direct Costs 11 11
2% 2%
14%
65 65
4% 4%
86%
- Selling and Administrative Expenses 96 96
7% 7%
126%
- Research and Development Expense 18 18
7% 7%
23%
-48 -48
6% 6%
-63%
- Depreciation and Amortization 0.61 0.61
12% 12%
1%
EBIT (Operating Income) EBIT -49 -49
6% 6%
-64%
Net Profit -49 -49
6% 6%
-64%

In millions USD.

Don't miss a Thing! We will send you all news about Sight Sciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sight Sciences Inc Stock News

Neutral
Seeking Alpha
14 days ago
Sight Sciences, Inc. (NASDAQ:SGHT ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Alison Perry Bauerlein - CFO, Principal Financial & Accounting Officer and Treasurer Matthew W. Link - Chief Commercial Officer Paul Badawi - Co-Founder, President, CEO & Director Conference Call Participants Danielle Joy Antalffy - UBS Investment Bank, Research Division Frank Jam...
Neutral
GlobeNewsWire
15 days ago
MENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported financial results for the second quarter ended June 30, 2025, and raised its revenue guidan...
Neutral
GlobeNewsWire
23 days ago
Cost-Utility Analysis published in the Expert Review of Pharmacoeconomics and Outcomes Research Cost-Utility Analysis published in the Expert Review of Pharmacoeconomics and Outcomes Research
More Sight Sciences Inc News

Company Profile

Sight Sciences, Inc. is a medical device company, which engages in the provision of glaucoma implants for treatment of irreversible blindness. It also develops pharmaceuticals, drug delivery systems, and diagnostics for the treatment of ophthalmic conditions. The firms products include viscosurgical system and trabeculotomy instrument. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Head office United States
CEO Paul Badawi
Employees 216
Founded 2011
Website www.sightsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today